Guidance on Waterborne Bacterial Pathogens
Table of Contents
- Background on guidance documents
- Part A. Guidance on waterborne bacterial pathogens
- Part B. Supporting information
- B.1 Waterborne faecal pathogens
- B.1.1 Pathogenic Escherichia coli
- B.1.1.1 Treatment technology
- B.1.1.2 Assessment
- B.1.2 Salmonella and Shigella
- B.1.2.1 Treatment technology
- B.1.2.2 Assessment
- B.1.3 Campylobacter and Yersinia
- B.1.3.1 Treatment technology
- B.1.3.2 Assessment
- B.1.1 Pathogenic Escherichia coli
- B.2 Waterborne non-faecal pathogens
- B.2.1 Legionella
- B.2.1.1 Sources and exposure
- B.2.1.2 Health effects
- B.2.1.3 Treatment technology
- B.2.1.4 Assessment
- B.2.2 Mycobacterium avium complex
- B.2.2.1 Sources and exposure
- B.2.2.2 Health effects
- B.2.2.3 Treatment technology
- B.2.2.4 Assessment
- B.2.3 Aeromonas
- B.2.3.1 Sources and exposure
- B.2.3.2 Health effects
- B.2.3.3 Treatment technology
- B.2.3.4 Assessment
- B.2.4 Helicobacter pylori
- B.2.4.1 Sources and exposure
- B.2.4.2 Health effects
- B.2.4.3 Treatment technology
- B.2.4.4 Assessment
- B.2.1 Legionella
- B.3 Issues of emerging interest
- B.4 Residential-scale treatment
- B.1 Waterborne faecal pathogens
- Part C. References and acronyms
- C.1 References
- C.2 List of acronyms
Download the entire report
(PDF format, 664 KB, 61 pages)
Organization: Health Canada
Type: Guidelines
Date published: 2013-02
Related Topics
Report a problem or mistake on this page
- Date modified: